Page 209 - Presents News Today

Oral presentation at 63rd American Society of Hematology Annual Meeting includes results from the HERACLES Phase 2 trial in 24 patients with steroid-resistant Grade III-IV gastrointestinal acute

I'm personally grateful that there are last-minute gift ideas that always seem to be well-received by most people and are truly thoughtful gifts. Ready?

Thank you, gift gods, that there are last-minute gift ideas that still seem to be well-received by most people and come across as thoughtful, even. Ready?

The holidays are quickly approaching, but there's still time to find the perfect gift.

Employees from PCPS’ Information Systems and Technology division coordinate Kiddie Christmas to benefit children in need within the school district.

The holidays are quickly approaching, but there's still time to find the perfect gift.

- No safety concerns have been noted in any trial participants - Trial builds on prior clinical data demonstrating pelareorep's ability to reverse immunosuppressive tumor microenvironments

- The primary endpoint of Clinical Benefit Rate at 24 weeks with the triplet combination was met - The triplet combination showed clinically meaningful activity after 3 lines of anti-HER2 therapies

STOCKHOLM, Dec. 10, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological

The holidays are quickly approaching, but there's still time to find the perfect gift.